VanEck Pharmaceutical ETF (PPH) Stock Price & Analysis
VanEck Pharmaceutical ETF (PPH) closed at USD 114.93 on Friday, October 23, 2026, down 1.78% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 117.01; the Oct 23, 2026 session ranged USD 114.53–116.68 on volume of 229,056 shares. Market capitalization is —, with a 52-week range of USD 90.74–118.03 (NGM). Source: Nexqual, retrieved October 24, 2026 at 14:54 UTC.
Also available as compact Markdown for AI agents: nexqual.com/PPH.md
Key facts (PPH)
- Total return with dividends: 1Y +26.9% vs S&P 500 +13.4%; 5Y +68.5% vs S&P 500 +76.9%.
Total return (dividends reinvested) (PPH)
| 1Y (from 2025-10-24) | 5Y (from 2021-10-25) | |
|---|---|---|
| Total return | +26.9% | +68.5% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | +27.0% | +11.0% |
| Volatility (annualized) | 18.4% | 16.4% |
| Max drawdown | -10.8% (Feb 2026→Apr 2026) | -19.6% (Apr 2022→Sep 2022) |
PPH options: expected move
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 27 | 25.2% | ±5.6% |
| Dec 18, 2026 | 55 | 21.9% | ±6.9% |
| Jan 15, 2027 | 83 | 23.3% | ±9.0% |
| Apr 16, 2027 | 174 | 22.1% | ±12.2% |
30-day implied volatility 22.4% vs 18% realized over the last 30 trading days. Put/call ratio (volume) 0.55. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 24, 2026 at 14:54 UTC)
| Price | USD 114.93 |
|---|---|
| Change | ▼ 1.78% (down) |
| Previous Close | USD 117.01 |
| Open | USD 116.68 |
| Day Range | USD 114.53 – 116.68 |
| 52-Week Range | USD 90.74 – 118.03 |
| Volume | 229,056 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (PPH)
Nexqual's technical model rates PPH "STRONG BUY" based on 5 bullish and 0 bearish signals across 127 daily candles, as of October 24, 2026 at 14:54 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 59.49 (neutral) |
| vs SMA50 | Above (USD 112.34) |
| MACD | 1.25 (positive) |
Financial Health Score (PPH)
Nexqual rates VanEck Pharmaceutical ETF's overall financial health "Mixed" across five dimensions, as of October 24, 2026 at 14:54 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BBH | VanEck Biotech ETF | USD 246.57 | ▼ 0.74% |
| HHH | Howard Hughes Holdings Inc. | USD 70.19 | ▲ 1.01% |
| RTH | VanEck Retail ETF | USD 267.89 | ▼ 1.72% |
| IYH | iShares U.S. Healthcare ETF | USD 75.4 | ▼ 1.08% |
| IHE | iShares U.S. Pharmaceutical ETF | USD 102.51 | ▼ 2.17% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 24, 2026 at 14:54 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt